InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,172.80
(
-0.13%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
83.13
(
-0.48%
)
Bitcoin
70,963.91
(
-0.68%
)
Post# of 73665
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Avoid

Send PM Follow Ignore
Followers 23
Posts 1671
Boards Moderated 0
Alias Born 09/04/2009

Avoid

Re: None

Saturday, 03/04/2017 2:52:15 PM

Saturday, March 04, 2017 2:52:15 PM

Post# of 73665
The company reports they have been in discussion with a number of potential partners with whom their promising patent-pending antibody drug for breast cancer can be developed.

http://www.marketwired.com/press-release/premier-biomedical-retires-convertible-debt-otcqb-biei-2200100.htm

$BIEI
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!